A Department of Health and Social Care (DHSC) spokesperson told JDRF: “We are doing everything appropriate to prepare for EU Exit on October 31. Our priority is for all patients to continue to have access to medicines and medical products when we leave the EU.
“We are working with all our partners and our plans should ensure the supply of medicines and medical products remains uninterrupted.”
The government is procuring extra freight capacity to ensure swift and reliable delivery of medicines and medical devices in the event of a no-deal Brexit.
These arrangements echo the plans put in place ahead of 29 March and will be essential to the continuation of medicines and medical products if the UK leaves the EU without a deal. DHSC also continues to centrally coordinate contingency measures to mitigate risks to supply.
They say this removes the need for any stockpiling at local level which could cause medicine shortages and put patient care at risk.
Novo Nordisk and Sanofi, two of the three main manufacturers of insulin have confirmed they will have at least 16 weeks of stocks in the UK so they will have time to resolve any problems that could occur at the border.
They are also working on alternative routes into the country – either by ferry or in the air. Lilly have told us they have similar plans.
Further information on the government’s preparations for a no deal Brexit can be found here.